Tamoxifen, Evista Prevent Breast Cancer

Links shared publicly online about this topic.

  • 1,226
    total visits

Tamoxifen, Evista Prevent Breast Cancer

webmd.com

Updated results from a large breast cancer prevention trial confirm that both the old standby tamoxifen and the osteoporosis drug Evista can substantially cut the risk of developing breast cancer in high-risk postmenopausal women.

View full resource at webmd.com

Tags: Cancer, Cancer Prevention, Breast Cancer, Osteoporosis, Osteoporosis Medication, Drug, Women's Health, Evista

  • Share

Most Recently Shared on April 21, 2010 at 9:07 pm By:

WebMD WebMD

Tamoxifen, Evista Prevent Breast Cancer: Study Shows Tamoxifen Is More Effective, but Evista May Have Less Risk http://bit.ly/9rxD5e

2 years ago...

Also Shared By:

WebMD_News WebMD_News

Heart Health Heart Health

Knoxville Hospital Knoxville Hospital

Mona  Jauhar Mona Jauhar


Show More...

Susan G. Komen for the Cure | Understanding Breast Cancer | Risk Factors and Prevention | Risk-Lowering Drugs

ww5.komen.org — “A great deal of research is being done on drugs that can lower the risk of breast cancer in women at higher risk. Tamoxifen and raloxifene are the most well-studied of these drugs. For a summary of reView full resource at ww5.komen.org

  • View Related
  • Share

Most Recently Shared on November 18, 2011 at 9:50 pm By:

NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute

cancer.gov — “NCI Cancer Bulletin for November 1, 2011 - National Cancer InstituteView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on November 2, 2011 at 1:33 pm By:

NCIBulletin NCI Cancer Bulletin Health News

Annual screening with chest x-ray does not reduce lung cancer deaths http://t.co/uXEj5DBp

5 months ago...

Femara May Beat Tamoxifen at Preventing Breast Cancer's Return: MedlinePlus

nlm.nih.gov — “Femara May Beat Tamoxifen at Preventing Breast Cancer's ReturnView full resource at nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on October 24, 2011 at 3:19 pm By:

hamtmclibrary TMC Library Medical Education

Femara May Beat Tamoxifen at Preventing Breast Cancer's Return: http://t.co/TWS6oL3K

6 months ago...

As reported earlier... | Facebook

facebook.com — “Columbia University Department of Surgery wrote: As reported earlier this year, the drug... Join Facebook to connect with Columbia University Department of Surgery and others you may know.View full resource at facebook.com

  • View Related
  • Share

Most Recently Shared on October 22, 2011 at 11:00 am By:

ColumbiaSurgery Columbia Surgery Hospital

Is exemestane effective in preventing all forms of breast cancer? http://t.co/Kv8YOItU

6 months ago...

Breast Cancer Research: Dr. Feldman Explains New Study on Exemestane | Columbia University Department of Surgery Blog

columbiasurgery.net — “As reported in the NYT, the drug exemestane was found to reduce breast cancer occurance in post-menopausal women at high risk of developing breast cancer.View full resource at columbiasurgery.net

  • View Related
  • Share

Most Recently Shared on October 20, 2011 at 5:15 pm By:

ColumbiaSurgery Columbia Surgery Hospital

What is exemestane? How is it used to prevent the?occurrence?of breast cancer in high risk women? http://t.co/S6ydEMcQ

6 months ago...

Which kind of doctor administers or prescribes Tamoxifen?

healthtap.com — “It depends on what the Tamoxifen is being used to treat. If used to treat breast cancer, it is mostly prescribed by an oncologist. However, tamoxifen can also be used as treatment for severe breast pain/fibrocystic disease, or for breast cancer prevention. In those cases a Primary Care Physician, General Surgeon, or Gynecologist may prescribe it.View full resource at healthtap.com

  • View Related
  • Share

Most Recently Shared on September 3, 2011 at 1:03 am By:

zadehmd Michael A. Zadeh, M.D. Doctor, Surgeon, and Physician

#HealthTap: Which kind of doctor administers or prescribes Tamoxifen? Answer http://t.co/F2FCJf2

7 months ago...

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast Ca - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 29, 2011 at 7:09 pm By:

Women Who Drink, Smoke Are Less Likely to Stick With Tamoxifen - Drugs.com MedNews

drugs.com — “Women at high risk for breast cancer who smoke and drink are less likely to stick with a drug regimen meant to prevent cancer, a new study finds. Researchers anView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 7:11 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Women Who Drink, Smoke Are Less Likely to Stick With Tamoxifen: TUESDAY, Aug. 23 -- Women at high risk for... http://t.co/NIMcmcS #drug

8 months ago...

Women Who Drink Smoke Are Less Likely to Stick With Tamoxifen - Addiction | Alcoholism | Drugs - MSN Health

health.msn.com — “Some prescribed the drug to prevent breast cancer may need help with adherence researchers sayView full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on August 23, 2011 at 6:39 pm By:

msnhealthnews msn Health News

Women Who Drink, Smoke Are Less Likely to Stick With Tamoxifen: http://t.co/5AIYPmm

8 months ago...

DNA Matters When Treating Breast Cancer « CBS Miami

miami.cbslocal.com — “Millions of women take the drug Tamoxifen to prevent their breast cancer from coming back or, if they are at high risk they may take it to avoid getting breast cancer. But a new study indicates that some women may not process the drug properly, making it is less effective at warding off cancer. News, Sports, Weather, Traffic and Miami's BestView full resource at miami.cbslocal.com

  • View Related
  • Share

Most Recently Shared on August 16, 2011 at 8:56 pm By:

Encouraging breast cancer prevention news. Tamoxifen wards off breast cancer's return for more than a decade http://ar.gy/Vsk

64.143.177.152 — “Encouraging breast cancer prevention news. Tamoxifen wards off breast cancer's return for more than a decade http://ar.gy/VskView full resource at 64.143.177.152

  • View Related
  • Share

Most Recently Shared on August 2, 2011 at 8:37 pm By:

sentarahealth Sentara Healthcare Hospital and Healthcare System

Encouraging breast cancer prevention news. Tamoxifen wards off breast cancer's return for more than a decade http://ar.gy/Vsk

9 months ago...

Drug's lasting benefits sees breast cancer deaths down by third

medicalxpress.com — “The benefits of using tamoxifen to prevent recurrence of breast cancer after surgery continue to accrue long after women stop taking the drug, a study led by Oxford University has found.View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on July 29, 2011 at 12:56 pm By:

FightCancer FightCancer Health News

Drug's lasting benefits sees breast cancer deaths down by third http://bit.ly/nxhEjQ

9 months ago...

UNC study looks at dose levels of the breast cancer drug, tamoxifen — UNC Lineberger Comprehensive Cancer Center

unclineberger.org — “Using a patient’s genetic information can be successfully used to manage the drug concentrations of tamoxifen, a drug used to treat and prevent breast cancer.View full resource at unclineberger.org

  • View Related
  • Share

Most Recently Shared on July 19, 2011 at 5:59 pm By:

UNC_Lineberger UNC Lineberger Hospital

UNC study looks at dose levels of the breast cancer drug, tamoxifen http://t.co/XypDyiX

9 months ago...

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast CA - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 4:32 pm By:

MedicalNews Medical News Health News

ASCO: Exemestane Scores for Primary Prevention of Breast CA (CME/CE) http://bit.ly/mecJgV

10 months ago...

Medical News: ASCO: Exemestane Scores for Primary Prevention of Breast CA - in Meeting Coverage, ASCO from MedPage Today

medpagetoday.com — “CHICAGO -- Make room, tamoxifen: The aromatase inhibitor exemestane (Aromasin) prevents first breast cancers in moderate- to high-risk postmenopausal women, according to randomized trial results.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on June 4, 2011 at 4:19 pm By:

FightCancer FightCancer Health News

ASCO: Exemestane Scores for Primary Prevention of Breast CA (CME/CE) http://bit.ly/lVq0E0

10 months ago...

Advertisement